Related to Illumina Institutes Poison Pill to Ward Off Roche’s $5.7B Purchase Proposal

• Illumina to Co-Market Caliper Technologies to Improve Sequencing Workflows
  
• Illumina Acquires Epicentre to Own Sequencing Library Preparation Technology
  
• PerkinElmer Steps into DNA Sequencing Market
  
• Genomic Health Reports Use of Illumina NGS Technology on Archived Tumors for Biomarker Discovery
  
• Roche Buys Germany-Based Clinical Lab Automation Firm PVT for €65M Up Front
  
• Roche Buys Mtm Labs for €130M Up Front for Cervical Cancer Diagnostics
  
• University of Oxford to Sequence Whole Genomes of 500 People Using Illumina Technology
  
• Verinata Enters Supply Agreement with Illumina for Sequencing Instruments
  
• Roche Acquires License to Nanopore Technology with Sights on $1,000 Whole Genome Sequencing
  
• Roche Buys HCV Therapeutics Firm Anadys for $230M in Cash
  
• British Columbia Cancer Agency Added to Illumina Genome Network
  
• New York Genome Center Launches Its First Project with Feinstein Institute
  
• Illumina's MiSeq to Support Molecular Profiling Service
  
• NY Genome Center Names President-Scientific Director
  
• Roche and Precision System Science Deal to Advance NGS
  
• GEN Readers Predict Roche’s Persistence in Pursuing Illumina Will Pay Off
  
• Roche Ups Bid for Illumina to $51 Per Share, or $6.5B
  
• Illumina Shuns Roche’s Improved Acquisition Offer of $6.5B
  
• Roche Outlines $5.7B Bid to Buy Illumina for $44.5 Per Share in Cash
  
• Illumina Shuns Roche’s $5.7 Bid, While Roche Prepares for the Long Haul